unknown
Stage
About
Cyclerion Therapeutics is a biopharmaceutical company focused on developing therapies that target soluble guanylate cyclase (sGC) to treat rare and serious diseases associated with cardiovascular and central nervous system disorders.
Explore Cyclerion Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.